ARTICLE | Clinical News
Rexahn preclinical data
May 12, 2014 7:00 AM UTC
In mouse xenograft models of cancer, RX-21101 completely inhibited tumor growth, enhanced tumor regression and improved survival without significant changes in body weight compared to IV docetaxel. Da...